Global and regional report

In this report, UNAIDS is announcing that 18.2 million people now have access to HIV treatment. The Fast-Track response is working. Increasing treatment coverage is reducing AIDS-related deaths among adults and children. But the life-cycle approach has to include more than just treatment. Tuberculosis (TB) remains among the commonest causes of illness and death among people living with HIV of all ages, causing about one third of AIDS-related deaths in 2015. These deaths could and should have been prevented.

The Double Dividend accelerates action towards ending paediatric HIV and AIDS and improving child survival. It provides evidence and emerging data to support initiatives that serve HIV exposed children and strengthen service delivery platforms.

Consultation on Clinical, Ethical and Operational Considerations for the implementation of Oral PreExposure Prophylaxis (PrEP) in Sexually Active Older Adolescents (15–19) at High Risk of HIV Infection

Synthesis Report of the Rapid Assessment of Adolescent and HIV Programme Context in Five Countries: Botswana, Cameroon, Jamaica, Swaziland and Zimbabwe.

The assessment process described in this report was designed to support countries to strengthen the adolescent component of their national HIV programmes. Through the review of existing data on HIV, health and development in adolescents the assessments are a systematic way to identify equity and performance gaps affecting adolescent HIV programming.

Greatly expanded access to routine viral load testing will be a game-changer in the global response to AIDS. Routine viral load tests improve treatment quality and individual health outcomes for people living with HIV, contribute to prevention, and potentially reduce resource needs for costly second- and third-line HIV medicines.

The AIDS movement, led by people living with and affected by HIV, continues to inspire the world and offer a model for a people-centred, rights-based approach to global health and social transformation. And yet, today, amid a swirl of competing and complex global concerns, we confront a serious new obstacle: the oppressive weight of complacency. This is happening when we know that if we make the right decisions and the right investments now, the end of AIDS can be within our grasp. This moment is, however, fleeting. We have a fragile window of opportunity—measured in months—in which to scale up.

This document explains the experiences of six countries in financing community responses through governmental mechanisms.

General Assembly Draft Resolution. Political Declaration on HIV and AIDS: On the Fast-Track to Accelerate the Fight against HIV and to End the AIDS Epidemic by 2030.

Humanitarian emergencies in countries with a high HIV disease burden can cause considerable PMTCT antiretroviral treatment (ART) interruption. The risk of drug resistance emerging is increased, efficacy of treatment compromised and the effective scale-up of lifelong ART for pregnant and breastfeeding women living with HIV is impeded. Therefore, strategies to ensure the uninterrupted supply of antiretrovirals for PMTCT during crises are needed. This paper highlights lessons learned from PMTCT implementation in emergencies based on reported literature, key informant interviews, and recommendations made. The review focuses on delivering ART for PMTCT.